Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 23 Mar 2022 for Rallybio Corp, €22k. Read the official filing
Filing timeline
BuySaleJeffrey M. Fryer
Insider track record
Disclosed buys
2
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
-1.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Jeffrey M. Fryer: trading record in brief
Jeffrey M. Fryer (chief executive) discloses dealings in Rallybio Corp to SEC (Form 4). In total, 3 filings cover trades dated from 28 July 2021 to 21 March 2022.
The open-market record is one-sided, with 2 purchases worth €33k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 2 purchases and no sales on the market.
On 23 March 2022 came the latest disclosure, an open-market purchase for €22k in Rallybio Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jeffrey M. Fryer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,000 shares@ US$8.0467.0% of flowCommon StockSEC:0000899243-22-011950:0
Canonical exit: 19 Jun 2022 (T+90)
1,400 shares@ US$8.7033.0% of flowCommon StockSEC:0000899243-22-002911:0
Canonical exit: 19 Apr 2022 (T+90)
32,648 sharesCommon StockSEC:0000899243-22-001629:0
3 of 3 declarations
